Tony Ross-Hellauer

Harald Semmelrock, Simone Kopeinik, Dieter Theiler et al.

Research is facing a reproducibility crisis, in which the results and findings of many studies are difficult or even impossible to reproduce. This is also the case in machine learning (ML) and artificial intelligence (AI) research. Often, this is the case due to unpublished data and/or source-code, and due to sensitivity to ML training conditions. Although different solutions to address this issue are discussed in the research community such as using ML platforms, the level of reproducibility in ML-driven research is not increasing substantially. Therefore, in this mini survey, we review the literature on reproducibility in ML-driven research with three main aims: (i) reflect on the current situation of ML reproducibility in various research fields, (ii) identify reproducibility issues and barriers that exist in these research fields applying ML, and (iii) identify potential drivers such as tools, practices, and interventions that support ML reproducibility. With this, we hope to contribute to decisions on the viability of different solutions for supporting ML reproducibility.

Valerie Bürger, Marlie Besouw, Jana Fehr et al.

Meta-research and Trustworthy AI (TAI) share common goals, namely improving evidence, robustness, and transparency, yet there is very little interplay between the two fields. To investigate the potential benefits of closer collaboration between the domains of TAI in healthcare and meta-research, we convened an interdisciplinary workshop funded by the Volkswagen Foundation in February 2025. The workshop aimed to collaboratively examine key tensions in translating AI ethics principles into practice and to identify potential solutions informed by meta-research approaches. A Design Thinking-informed co-creation approach was followed by an inductive descriptive analysis of the outputs. Our results demonstrate how meta-research can offer concrete contributions to address pressing challenges of TAI in healthcare. These challenges include achieving robustness, reproducibility, and replicability; late-stage development and the integration of AI into clinical practice; the selection of appropriate evaluation metrics; specific AI-related challenges in preclinical and biomedical research; gaps of transparency in medical AI, as well as the need for improved conceptual clarity and AI literacy among stakeholders. Finally, we offer a catalog of ideas and roadmap for future research to inform scholars in both fields on existing interconnections and serve as a foundation for guiding future interdisciplinary efforts.

Harald Semmelrock, Tony Ross-Hellauer, Simone Kopeinik et al.

Many research fields are currently reckoning with issues of poor levels of reproducibility. Some label it a "crisis", and research employing or building Machine Learning (ML) models is no exception. Issues including lack of transparency, data or code, poor adherence to standards, and the sensitivity of ML training conditions mean that many papers are not even reproducible in principle. Where they are, though, reproducibility experiments have found worryingly low degrees of similarity with original results. Despite previous appeals from ML researchers on this topic and various initiatives from conference reproducibility tracks to the ACM's new Emerging Interest Group on Reproducibility and Replicability, we contend that the general community continues to take this issue too lightly. Poor reproducibility threatens trust in and integrity of research results. Therefore, in this article, we lay out a new perspective on the key barriers and drivers (both procedural and technical) to increased reproducibility at various levels (methods, code, data, and experiments). We then map the drivers to the barriers to give concrete advice for strategies for researchers to mitigate reproducibility issues in their own work, to lay out key areas where further research is needed in specific areas, and to further ignite discussion on the threat presented by these urgent issues.